Skip to main content
. 2017 Mar 13;11:519–530. doi: 10.2147/PPA.S129333

Table 1.

Rheumatologist-stated prescribing of biosimilars currently and expected in 12 months

Currently prescribing
Expect to be prescribing in 12 months
RA AxSpa PsA RA AxSpa PsA
N 49 49 48 50 50 50
Percentage of total prescribed drugs 2.7 3.3 3.0 4.1 5.1 4.0
Percentage of total prescribed biologic therapies 7.9 9.1 9.0 12.4 14.7 12.2

Note: N, number of rheumatologists responding.

Abbreviations: AxSpa, ankylosing spondyloarthritis; PsA, psoriatic arthritis; RA, rheumatoid arthritis.